- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
NEW YORK ( TheStreet) -- Santarus (Nasdaq: SNTS) hit a new 52-week high Tuesday as it is currently trading at $6.97, above its previous 52-week high of $6.93 with 426,605 shares traded as of 3:50 p.m. ET. Average volume has been 520,800 shares over the past 30 days. Santarus has a market cap of $429.6 million and is part of the health care sector and drugs industry. Shares are up 106.3% year to date as of the close of trading on Monday. Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company has a P/E ratio of 76.2, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.